The multifaceted roles of interleukin-36 in liver diseases: from pathogenesis to therapeutic potential
International Immunopharmacology · 2026-05 · 177 · 116566
DOI: 10.1016/j.intimp.2026.116566 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Immunopharmacology, 2026-05. Verfasst von Gui-Rong Rao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Central Laboratory, Air Force Hospital of Southern Theatre Command, Guangzhou 510602, Guangdong, China. Hauptthemen laut MEDLINE: Interleukin-1, Liver Diseases, Liver. Die Arbeit nennt 91 Literaturangaben.
Abstract (Originalsprache)
Interleukin-36 (IL-36), a member of the IL-1 cytokine superfamily, has emerged as a critical regulator of immune and inflammatory responses in the liver. Accumulating evidence reveals that IL-36 orchestrates hepatic inflammation, injury, and repair in a highly context-dependent manner. We propose a unified "IL-36 switch" framework wherein functional outcomes are determined by three interrelated factors: the cellular source of IL-36 ligands (neutrophil-derived in acute settings versus hepatocyte-derived in chronic disease), the duration and magnitude of signaling, and the evolving cellular composition of the diseased liver. This review synthesizes recent findings elucidating the context-dependent functions of IL-36 across the spectrum of liver pathologies. In acute liver injury, transient IL-36 signals maintain immune homeostasis and promote tissue repair, whereas sustained signaling in chronic conditions drives pathological inflammation, steatosis, and fibrogenesis. The Toll-like receptor 3-IL-36-neutrophil extracellular traps axis in acute liver failure and IL-36-mediated gut-liver axis dysregulation in cirrhosis represent novel pathogenic mechanisms. In hepatocellular carcinoma, compartment-specific discrepancies (low intratumoral but high circulating IL-36) and ligand-specific effects reveal complex tumor-immune interactions. We critically evaluate the translational potential of IL-36 targeting, considering evidence from successful IL-36R blockade in pustular psoriasis, while emphasizing critical caveats including species-specific differences between murine models and human disease, infection risk, and the need to preserve homeostatic functions. Finally, we identify key knowledge gaps and propose a future research program to investigate the therapeutic potential of IL-36 modulation in liver diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Central Laboratory, Air Force Hospital of Southern Theatre Command, Guangzhou 510602, Guangdong, China.
- School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China; Clinical Pharmacy Programme, The University of Manchester, Manchester M139PL, United Kingdom.
- Department of Infectious Diseases, Tangdu Hospital, Fourth Military Medical University, Xi'an 710038, Shaanxi Province, China.
- Department of Infectious Diseases, Air Force Hospital of Southern Theatre Command, Guangzhou 510602, Guangdong, China.
- Department of Infectious Diseases, Tangdu Hospital, Fourth Military Medical University, Xi'an 710038, Shaanxi Province, China. Electronic address: lianjq@fmmu.edu.cn.
- Department of Infectious Diseases, Tangdu Hospital, Fourth Military Medical University, Xi'an 710038, Shaanxi Province, China. Electronic address: zhangyefmmu@hotmail.com.
Zitieren
APA
Rao, G. R., Zhang, S. M., Yang, X. F., Luo, L. M., Lian, J. Q., & Zhang, Y. (2026). The multifaceted roles of interleukin-36 in liver diseases: from pathogenesis to therapeutic potential. International Immunopharmacology, 177, 116566. https://doi.org/10.1016/j.intimp.2026.116566
Vancouver
Rao GR, Zhang SM, Yang XF, Luo LM, Lian JQ, Zhang Y. The multifaceted roles of interleukin-36 in liver diseases: from pathogenesis to therapeutic potential. International Immunopharmacology. 2026;177:116566. doi:10.1016/j.intimp.2026.116566
BibTeX
@article{Rao2026,
author = {Rao, Gui-Rong and Zhang, Shu-Ming and Yang, Xiao-Fei and Luo, Li-Min and Lian, Jian-Qi and Zhang, Ye},
title = {The multifaceted roles of interleukin-36 in liver diseases: from pathogenesis to therapeutic potential},
journal = {International Immunopharmacology},
year = {2026},
volume = {177},
pages = {116566},
doi = {10.1016/j.intimp.2026.116566}
}
EUVIMED